Australia's most trusted
source of pharma news
Wednesday, 19 November 2025
Wednesday, 19 November 2025
Subscribe
Login
News Headlines
News Headlines
News
J&J buys 'cancer revolution' asset
Posted 19 November 2025 AM
Johnson & Johnson is boasting that it's "set to revolutionise the treatment of cancer" with the acquisition of Halda Therapeutics whose lead asset promises a "highly differentiated" treatment for prostate cancer.
HLD-0915, is a once-daily clinical-stage therapy that J&J believes has the potential to transform patient outcomes with its novel precision cancer cell-killing approach that can overcome mechanisms of resistance to treatment. It was granted fast track designation by the FDA in August.
To see the whole article, please login
Posted 19 November 2025 AM
Johnson & Johnson is boasting that it's "set to revolutionise the treatment of cancer" with the acquisition of Halda Therapeutics whose lead asset promises a "highly differentiated" treatment for prostate cancer.
HLD-0915, is a once-daily clinical-stage therapy that J&J believes has the potential to transform patient outcomes with its novel precision cancer cell-killing approach that can overcome mechanisms of resistance to treatment. It was granted fast track designation by the FDA in August.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (15)
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - Belrose
- Customer Service Representative - St Leonards
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
- Customer Service Representative - Macquarie Park
- GP Sales Representative - Cronulla - AstraZeneca - Cronulla, NSW
- GP Sales Representative - NSW Mid North Coast - AstraZeneca - NSW
Clinical & Medical, R&D (5)
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
- QC Scientist - 40120 - Broadmeadows
Regulatory, Pharmacovigilance & QA (5)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
- Quality assurance associate - Sydney
- Pharmacovigilance Associate - Sydney
Other (13)
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- Senior Recruitment Consultant - Sydney
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
- Warehouse & Logistics Officer - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Financial Analyst - Melbourne
- Senior Manager - Cell Therapy - Australia - AstraZeneca - Sydney or Melbourne
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.